ZYG11B
protein-codingzyg-11 family member B, cell cycle regulator, the group of ZYG11 cell cycle regulator family|Armadillo like helical domain containing
Gene summary
Involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process and protein quality control for misfolded or incompletely synthesized proteins. Part of Cul2-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Jul 2025]
- ZYG11
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~100.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019042
Submitter: LiferaOmics
Genetic evidence – Published (AR scope) No scorable published cases of biallelic (autosomal recessive) ZYG11B variants causing oculo-auriculo-vertebral spectrum were identified. Published genetic evidence total = 0 / 12 Published (AD context; not scored for AR) ZYG11B-related oculo-auriculo-vertebral spectrum has been reported in an autosomal dominant (de novo heterozygous) context (PMID: 32738032). This evidence is not scorable under the autosomal recessive model. AD-context evidence total (not scored for AR) = 0 Genetic evidence – Our case Family 1 – one proband. Case-level (AR homozygous; predicted null frameshift; AR predicted null default = 1.5; consanguineous family → −0.5 applied) = 1.0; Segregation = 0; Case-control = 0 Family 1 total = 1.0 Total genetic evidence (Published AR + Our case) 1.0 / 12 Experimental evidence – Published (biological plausibility only; conservative) ZYG11B has been shown to play a role in craniofacial and axial development. Zebrafish knockdown models demonstrate craniofacial and vertebral abnormalities, supporting biological plausibility for involvement in oculo-auriculo-vertebral spectrum. Model system (gene role in craniofacial development; biological plausibility only) = 0.5 Experimental evidence total = 0.5 / 6 Overall score Genetic evidence = 1.0 Experimental evidence = 0.5 Total = 1.5
Inheritance Pattern: AD
Disease ID:MONDO:0019042
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZYG11B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024646.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 56 | 56 | ||||
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 8 | 8 | ||||
| Total | 0 | 1 | 69 | 0 | 0 | 70 |
Highest pathogenic variant AF is 0.0000013686443
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_078922.1 | 14 | MANE Select | |
| Ensembl | ENSP00000294353.6 | 14 | MANE Select | |
| RefSeq | NP_001428883.1 | 14 | Standard | |
| Ensembl | ENSP00000441315.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein ubiquitination
Cellular Component
- Cul2-RING ubiquitin ligase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000294353
- Coding exons
- 14
- Length
- 100889
- Individuals with no LoFs
- 125724
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 20
- Defined
- 125745
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.98 | 176 | 400 | 0.440 | 0.0000207 | 4902 |
| Missense (PolyPhen) | 27 | 76.35 | 0.35363 | 970 | ||
| Synonymous | -0.971 | 156 | 141 | 1.10 | 0.00000685 | 1439 |
| Loss of Function | 4.97 | 4 | 36.3 | 0.110 | 0.00000193 | 419 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00014 | 0.00012 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.000079 | 0.000070 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probably acts as target recruitment subunit in the E3 ubiquitin ligase complex ZYG11B-CUL2-Elongin BC.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.362
- RVIS EVS
- -1
- RVIS percentile EVS
- 8.32
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.662
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |